BusnachG., FranceschiniG., ChiesaG.Impaired efficacy of selective LDL-apheresis in primary biliary cirrhosis. Int J Artif Organs1991; 14: 246–50.
3.
AraiH., NagumoK., NakajimaM., KojimaS., HirayamaK., YamazakiM.Effect of low-density lipoprotein apheresis on a patient with cerebrotendinous xanthomatosis. Jpn J Apheresis1995; 14: 59–60.
4.
YanagisawaT., OtsuboO., NozakiH.Massive proteinuria after renal transplantation treated with LDL-apheresis. Transplant Proc1996; 28: 1482–3.
5.
KanemitsuS., TakekoshiN., MatsuiS.Short-term and long-term effects of low-density lipoprotein (LDL) apheresis on restenosis after percutaneous transluminal coronary angioplasty (PTCA): is lowering Lp(a) by LDL apheresis effective on restenosis after PTCA?Therapeutic Apheresis1998; 2: 65–70.
6.
YoshidomeH., KuriyamaM., FujiyamaM., OsameM.Serum amyloid A and P protein levels are lowered by dextran sulfate cellulose low-density lipoprotein apheresis. Artif Organs1998; 22: 144–8.
7.
TaniguchiY., YoriokaN., YamashitaK.Immunohistochemical localization of apolipoprotein E in renal amyloidosis. Hiroshima J Med Sci1996; 45: 11–4.
8.
RuanX.Z., VargheseZ., FernandoR., MoorheadJ.F.Cytokine regulation of low-density lipoprotein receptor gene transcription in human mesangial cells. Nephrol Dial Transplant1998; 13: 1391–7.
